Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 22515)

1.

[Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial].

Woggon B, Dick P, Fleischhauer HJ, Gmür M, Gruber G, Angst J, Heimann H.

Int Pharmacopsychiatry. 1977;12(4):193-209. German.

PMID:
22515
2.

A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients.

Chouinard G, Annable L, Kropsky M.

J Clin Pharmacol. 1978 Feb-Mar;18(2-3):148-54.

PMID:
24061
3.
4.

A comparative study with pipothiazine palmitate and fluphenazine enanthate in the treatment of schizophrenic patients.

Jain RC, Ananth JV, Lehmann HE, Ban TA.

Curr Ther Res Clin Exp. 1975 Oct;18(4):585-9. No abstract available.

PMID:
241609
5.

How schizophrenic patients change during 3 years' treatment with depot neuroleptics.

Dencker SJ, Frankenberg K, Lepp M, Lindberg D, Malm U.

Acta Psychiatr Scand. 1978 Feb;57(2):115-23.

PMID:
24982
7.
8.

A comparative trial of depot pipothiazine.

Steinert J, Neder A, Erba E, Pugh CR, Robinson C, Priest RG.

J Int Med Res. 1986;14(2):72-7.

PMID:
2870944
9.
11.

A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.

Chouinard G, Annable L, Campbell W.

J Clin Psychopharmacol. 1989 Aug;9(4):247-53.

PMID:
2570086
12.

Three years' maintenance neuroleptic treatment in schizophrenia--before and beyond.

Dencker SJ, Frankenberg K, Lepp M, Lindberg D, Malm U.

Acta Psychiatr Scand. 1978 Feb;57(2):103-14.

PMID:
24981
13.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
14.

Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.

Simon P, Fermanian J, Ginestet D, Goujet MA, Péron-Magnan P.

Arch Gen Psychiatry. 1978 Jul;35(7):893-7.

PMID:
28102
15.

A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.

Dencker SJ, Frankenberg K, Malm U, Zell B.

Acta Psychiatr Scand Suppl. 1973;241:101-18. No abstract available.

PMID:
4147508
16.

Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia.

McClelland HA, Farquharson RG, Leyburn P, Furness JA, Schiff AA.

Arch Gen Psychiatry. 1976 Dec;33(12):1435-9.

PMID:
11760
17.

A preliminary evaluation of pipothiazine palmitate in schizophrenia.

Imlah NW, Murphy KP.

Curr Med Res Opin. 1975;3(3):169-74.

PMID:
238791
18.

A comparative trail of fluphenazine decanoate and flupenthixol decanoate.

Haslam MT, Bromham BM, Schiff AA.

Acta Psychiatr Scand. 1975 Feb;51(2):92-100.

PMID:
1091124
19.

Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.

Frangos H, Zissis NP, Leontopoulos I, Diamantas N, Tsitouridis S, Gavriil I, Tsolis K.

Acta Psychiatr Scand. 1978 May;57(5):436-46.

PMID:
354331
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk